Treatment need may increase 16 percent by 2025
New evidence in fight against stage 2 glioma
Q&A with Dr. Isabelle Choi, Radiation oncologist at New York Proton Center
A look back at some of the biggest headlines shaping the road ahead
Developed as upgrade to current MRIdian system
Testing approach on head-and-neck and brain tumor patients
Legislation passed in December to delay implementation
Inhibiting a protein receptor topically may yield better cosmetic and functional outcomes
Researchers say it may allow for smaller margins around targeted tumors
Manufacturing issues could have affected quality of Lutathera, Pluvicto treatments
The insurer administered ERISA plans to block coverage because it was too expensive, alleges the suit
Proton therapy spares the heart from radiation-related cardiac toxicity
Access is improving for the kids who stand to benefit most, but the pandemic has magnified financial challenges
The latest treatment innovations entering the market
Proposed six percent cuts could have shut down many freestanding clinics